1. Medtech Insight
  2. >>Archive

Thoratec Looks To Next-Generation LVADs To Revive Sinking Sales

Thoratec reported a near 10 percent year-over-year decline in revenue in the second quarter; physicians have become more selective about which patients to implant with a HeartMate II ventricular assist device, the firm says. The company is looking to next-generation of HeartMate products as well as the technology it acquired in the Apica deal to help it return to growth.

Thoratec Corp. is counting on its future product pipeline, especially HeartMate III and HeartMate PHP, to drive revenue growth in its struggling flagship HeartMate ventricular assist device business.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight